As one of the frontrunners in the contract manufacture of monoclonal antibodies (mAbs) and recombinant proteins, Creative Biolabs produces the essential ingredients for tomorrow's life-saving medicines covering the whole process of drug development and manufacture. Our product facilities can provide fully GMP, GLP, GCP, CAP and CLIA compliant services for consistent quality to meet all regulatory requirements. Our customers range from international pharmaceutical companies and large biotechnology businesses to new start-ups. At Creative Biolabs, we are prepared to meet the needs of the market and our clients to provide the best solution for your pipeline.
Creative Biolabs’ process R&D services range from vector construction and cell line development to full-scale manufacturing. These include a complete range of analytical services and regulatory support for pre-clinical, clinical trials and in-market supply. Our customers regularly ask us to perform tailored work packages or the complete development program. We have an expansive line of cutting edge Development Technologies available to enhance your expression process. From early protein target risk assessment programs to our continually upgraded and highly efficient proprietary HostOptimTM technology enables generation of high yielding production systems across different industry relevant platforms (e.g. CHO, HEK293, Pichia pastoris), we are able to achieve higher titers, while improving speed to market, safety and costs.
Our customers may request Creative Biolabs to perform the complete development program or individual work packages. We offer a full line development and manufacturing capabilities from DNA to BLA.
• Early Drug discovery & Development
• Formulation Services
• API Service (GLP, GLP+/GMP-like & GMP)
• Analytical Service